{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:18:37Z","timestamp":1779383917793,"version":"3.53.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02051-2","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:34:48Z","timestamp":1777689288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aging alters the vulnerability pattern to amyloid-beta oligomers in wild-type mice: a behavioral and neurobiological study"],"prefix":"10.1186","volume":"18","author":[{"given":"Ahmad","family":"Allouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Birck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Tallandier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Baldoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Afrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Violle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"1","key":"2051_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00663-w","volume":"12","author":"M Tolar","year":"2020","unstructured":"Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M. Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval. Alzheimers Res Ther. 2020;12(1):95. https:\/\/doi.org\/10.1186\/s13195-020-00663-w.","journal-title":"Alzheimers Res Ther"},{"issue":"20","key":"2051_CR2","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","volume":"389","author":"RJ Bateman","year":"2023","unstructured":"Bateman RJ, Smith J, Donohue MC, et al. Two phase 3 trials of gantenerumab in early Alzheimer\u2019s disease. N Engl J Med. 2023;389(20):1862\u201376. https:\/\/doi.org\/10.1056\/NEJMoa2304430.","journal-title":"N Engl J Med"},{"issue":"1","key":"2051_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"issue":"22","key":"2051_CR4","doi-asserted-by":"publisher","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","volume":"90","author":"AE Roher","year":"1993","unstructured":"Roher AE, Lowenson JD, Clarke S, et al. Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(22):10836\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2051_CR5","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","volume":"13","author":"CJ Pike","year":"1993","unstructured":"Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci Off J Soc Neurosci. 1993;13(4):1676\u201387. https:\/\/doi.org\/10.1523\/JNEUROSCI.13-04-01676.1993.","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"10","key":"2051_CR6","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5481\u2013503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2051_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary JP, Walsh DM, Hofmeister JJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 2005;8(1):79\u201384. https:\/\/doi.org\/10.1038\/nn1372.","journal-title":"Nat Neurosci"},{"issue":"2","key":"2051_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101\u201312. https:\/\/doi.org\/10.1038\/nrm2101.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2051_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci. 2012;15(3):349\u201357. https:\/\/doi.org\/10.1038\/nn.3028.","journal-title":"Nat Neurosci"},{"issue":"11","key":"2051_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jalz.2019.09.075","volume":"16","author":"M Tolar","year":"2020","unstructured":"Tolar M, Abushakra S, Sabbagh M. The path forward in Alzheimer\u2019s disease therapeutics: reevaluating the amyloid cascade hypothesis. Alzheimers Dement. 2020;16(11):1553\u201360. https:\/\/doi.org\/10.1016\/j.jalz.2019.09.075.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2051_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1039\/C6CS00731G","volume":"46","author":"SJC Lee","year":"2017","unstructured":"Lee SJC, Nam E, Lee HJ, Savelieff MG, Lim MH. Towards an understanding of amyloid-\u03b2 oligomers: characterization, toxicity mechanisms, and inhibitors. Chem Soc Rev. 2017;46(2):310\u201323. https:\/\/doi.org\/10.1039\/C6CS00731G.","journal-title":"Chem Soc Rev"},{"issue":"6","key":"2051_CR12","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awv024","volume":"138","author":"A Baker-Nigh","year":"2015","unstructured":"Baker-Nigh A, Vahedi S, Davis EG, et al. Neuronal amyloid-\u03b2 accumulation within cholinergic basal forebrain in ageing and Alzheimer\u2019s disease. Brain. 2015;138(6):1722\u201337. https:\/\/doi.org\/10.1093\/brain\/awv024.","journal-title":"Brain"},{"issue":"46","key":"2051_CR13","doi-asserted-by":"publisher","first-page":"28757","DOI":"10.1074\/jbc.271.46.28757","volume":"271","author":"T Pillot","year":"1996","unstructured":"Pillot T, Goethals M, Vanloo B, et al. Fusogenic Properties of the C-terminal Domain of the Alzheimer \u03b2-Amyloid Peptide. J Biol Chem. 1996;271(46):28757\u201365. https:\/\/doi.org\/10.1074\/jbc.271.46.28757.","journal-title":"J Biol Chem"},{"issue":"4","key":"2051_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor PN, Buniel MC, Furlow PW, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J Neurosci. 2007;27(4):796\u2013807. https:\/\/doi.org\/10.1523\/JNEUROSCI.3501-06.2007.","journal-title":"J Neurosci"},{"issue":"8","key":"2051_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, et al. Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14(8):837\u201342. https:\/\/doi.org\/10.1038\/nm1782.","journal-title":"Nat Med"},{"issue":"12","key":"2051_CR16","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1089\/ars.2011.4173","volume":"16","author":"K Leuner","year":"2012","unstructured":"Leuner K, Sch\u00fctt T, Kurz C, et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal. 2012;16(12):1421\u201333. https:\/\/doi.org\/10.1089\/ars.2011.4173.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2051_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. 2020;15(1):30. https:\/\/doi.org\/10.1186\/s13024-020-00376-6.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2051_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.nbd.2006.02.010","volume":"23","author":"C Malaplate-Armand","year":"2006","unstructured":"Malaplate-Armand C, Florent-B\u00e9chard S, Youssef I, et al. Soluble oligomers of amyloid-\u03b2 peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis. 2006;23(1):178\u201389. https:\/\/doi.org\/10.1016\/j.nbd.2006.02.010.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"2051_CR19","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, et al. Oligomeric amyloid \u03b2 associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A. 2009;106(10):4012\u20137. https:\/\/doi.org\/10.1073\/pnas.0811698106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2051_CR20","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/brain\/awt171","volume":"136","author":"BG Perez-Nievas","year":"2013","unstructured":"Perez-Nievas BG, Stein TD, Tai HC, et al. Dissecting phenotypic traits linked to human resilience to Alzheimer\u2019s pathology. Brain J Neurol. 2013;136(8):2510\u201326. https:\/\/doi.org\/10.1093\/brain\/awt171.","journal-title":"Brain J Neurol"},{"key":"2051_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S, Lipton SA, Xu H. Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:48. https:\/\/doi.org\/10.1186\/1750-1326-9-48.","journal-title":"Mol Neurodegener"},{"key":"2051_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","volume":"6","author":"U Sengupta","year":"2016","unstructured":"Sengupta U, Nilson AN, Kayed R. The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy. EBioMedicine. 2016;6:42\u20139. https:\/\/doi.org\/10.1016\/j.ebiom.2016.03.035.","journal-title":"EBioMedicine"},{"issue":"1","key":"2051_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03163-y","volume":"21","author":"S Lista","year":"2024","unstructured":"Lista S, Imbimbo BP, Grasso M, et al. Tracking neuroinflammatory biomarkers in Alzheimer\u2019s disease: a strategy for individualized therapeutic approaches? J Neuroinflammation. 2024;21(1):187. https:\/\/doi.org\/10.1186\/s12974-024-03163-y.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"2051_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.503","volume":"4","author":"B Parajuli","year":"2013","unstructured":"Parajuli B, Sonobe Y, Horiuchi H, Takeuchi H, Mizuno T, Suzumura A. Oligomeric amyloid \u03b2 induces IL-1\u03b2 processing via production of ROS: implication in Alzheimer\u2019s disease. Cell Death Dis. 2013;4(12):e975. https:\/\/doi.org\/10.1038\/cddis.2013.503.","journal-title":"Cell Death Dis"},{"issue":"7638","key":"2051_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137. https:\/\/doi.org\/10.1038\/nature21029.","journal-title":"Nature"},{"issue":"1","key":"2051_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"2051_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/17460441.2015.1041913","volume":"10","author":"D Puzzo","year":"2015","unstructured":"Puzzo D, Gulisano W, Palmeri A, Arancio O. Rodent models for Alzheimer\u2019s disease drug discovery. Expert Opin Drug Discov. 2015;10(7):703\u201311. https:\/\/doi.org\/10.1517\/17460441.2015.1041913.","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"2051_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00712-0","volume":"19","author":"MZ Zhong","year":"2024","unstructured":"Zhong MZ, Peng T, Duarte ML, Wang M, Cai D. Updates on mouse models of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19(1):23. https:\/\/doi.org\/10.1186\/s13024-024-00712-0.","journal-title":"Mol Neurodegener"},{"issue":"10","key":"2051_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105404","volume":"23","author":"R Sanchez-Varo","year":"2022","unstructured":"Sanchez-Varo R, Mejias-Ortega M, Fernandez-Valenzuela JJ, et al. Transgenic mouse models of Alzheimer\u2019s disease: an integrative analysis. Int J Mol Sci. 2022;23(10):5404. https:\/\/doi.org\/10.3390\/ijms23105404.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2051_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052805","volume":"25","author":"MS P\u00e1dua","year":"2024","unstructured":"P\u00e1dua MS, Guil-Guerrero JL, Prates JAM, Lopes PA. Insights on the use of transgenic mice models in Alzheimer\u2019s disease research. Int J Mol Sci. 2024;25(5):2805. https:\/\/doi.org\/10.3390\/ijms25052805.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"2051_CR31","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1523\/JNEUROSCI.4182-09.2010","volume":"30","author":"P Garcia","year":"2010","unstructured":"Garcia P, Youssef I, Utvik JK, et al. Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci. 2010;30(22):7516\u201327. https:\/\/doi.org\/10.1523\/JNEUROSCI.4182-09.2010.","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"3","key":"2051_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-151110","volume":"52","author":"J Colin","year":"2016","unstructured":"Colin J, Allouche A, Chauveau F, et al. Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-\u03b2 Peptide. J Alzheimers Dis JAD. 2016;52(3):975\u201387. https:\/\/doi.org\/10.3233\/JAD-151110.","journal-title":"J Alzheimers Dis JAD"},{"issue":"1","key":"2051_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3233\/JAD-170489","volume":"62","author":"W Watremez","year":"2018","unstructured":"Watremez W, Jackson J, Almari B, et al. Stabilized Low-n Amyloid-\u03b2 Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat. J Alzheimers Dis JAD. 2018;62(1):213\u201326. https:\/\/doi.org\/10.3233\/JAD-170489.","journal-title":"J Alzheimers Dis JAD"},{"issue":"3","key":"2051_CR34","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","volume":"78","author":"P Schuck","year":"2000","unstructured":"Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J. 2000;78(3):1606\u201319. https:\/\/doi.org\/10.1016\/S0006-3495(00)76713-0.","journal-title":"Biophys J"},{"issue":"2","key":"2051_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/CS20050163","volume":"110","author":"MV Chao","year":"2006","unstructured":"Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond Engl 1979). 2006;110(2):167\u201373. https:\/\/doi.org\/10.1042\/CS20050163.","journal-title":"Clin Sci (Lond Engl 1979)"},{"issue":"12","key":"2051_CR36","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41386-022-01373-7","volume":"47","author":"C Wang","year":"2022","unstructured":"Wang C, Zhang Y, Zhao D, et al. Phenazopyridine promotes RPS23RG1\/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2022;47(12):2042\u201350. https:\/\/doi.org\/10.1038\/s41386-022-01373-7.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"issue":"6","key":"2051_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001190.pub3","volume":"6","author":"JS Birks","year":"2018","unstructured":"Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2018;6(6):CD001190. https:\/\/doi.org\/10.1002\/14651858.CD001190.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2051_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","volume":"31","author":"E Dere","year":"2007","unstructured":"Dere E, Huston JP, De Souza Silva MA. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev. 2007;31(5):673\u2013704. https:\/\/doi.org\/10.1016\/j.neubiorev.2007.01.005.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"2051_CR39","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848\u201358. https:\/\/doi.org\/10.1038\/nprot.2006.116.","journal-title":"Nat Protoc"},{"issue":"11","key":"2051_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111898","volume":"9","author":"NJ Izzo","year":"2014","unstructured":"Izzo NJ, Staniszewski A, To L, et al. Alzheimer\u2019s therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits. PLoS ONE. 2014;9(11):e111898. https:\/\/doi.org\/10.1371\/journal.pone.0111898.","journal-title":"PLoS ONE"},{"issue":"5","key":"2051_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nsmb.1799","volume":"17","author":"M Ahmed","year":"2010","unstructured":"Ahmed M, Davis J, Aucoin D, et al. Structural conversion of neurotoxic amyloid-\u03b2(1\u201342) oligomers to fibrils. Nat Struct Mol Biol. 2010;17(5):561\u20137. https:\/\/doi.org\/10.1038\/nsmb.1799.","journal-title":"Nat Struct Mol Biol"},{"issue":"5618","key":"2051_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300(5618):486\u20139. https:\/\/doi.org\/10.1126\/science.1079469.","journal-title":"Science"},{"issue":"10","key":"2051_CR43","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.neurobiolaging.2009.11.007","volume":"32","author":"MN Reed","year":"2011","unstructured":"Reed MN, Hofmeister JJ, Jungbauer L, et al. Cognitive effects of cell-derived and synthetically derived A\u03b2 oligomers. Neurobiol Aging. 2011;32(10):1784\u201394. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.11.007.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"2051_CR44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/jnc.13443","volume":"136","author":"MK Jana","year":"2016","unstructured":"Jana MK, Cappai R, Pham CLL, Ciccotosto GD. Membrane-bound tetramer and trimer A\u03b2 oligomeric species correlate with toxicity towards cultured neurons. J Neurochem. 2016;136(3):594\u2013608. https:\/\/doi.org\/10.1111\/jnc.13443.","journal-title":"J Neurochem"},{"issue":"6880","key":"2051_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416(6880):535\u20139. https:\/\/doi.org\/10.1038\/416535a.","journal-title":"Nature"},{"issue":"6","key":"2051_CR46","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","volume":"277","author":"M Sakono","year":"2010","unstructured":"Sakono M, Zako T. Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J. 2010;277(6):1348\u201358. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07568.x.","journal-title":"FEBS J"},{"issue":"11","key":"2051_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jalz.2015.01.005","volume":"11","author":"JM Mc Donald","year":"2015","unstructured":"Mc Donald JM, O\u2019Malley TT, Liu W, et al. The aqueous phase of Alzheimer\u2019s disease brain contains assemblies built from \u223c4 and \u223c7 kDa A\u03b2 species. Alzheimers Dement J Alzheimers Assoc. 2015;11(11):1286\u2013305. https:\/\/doi.org\/10.1016\/j.jalz.2015.01.005.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2051_CR48","doi-asserted-by":"crossref","unstructured":"Flurkey K, Currer J, Harrison D. Mouse models in aging research. Fac Res 2000 - 2009. Published online January 1, 2007:637\u2013672.","DOI":"10.1016\/B978-012369454-6\/50074-1"},{"issue":"4","key":"2051_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nrn3200","volume":"13","author":"JH Morrison","year":"2012","unstructured":"Morrison JH, Baxter MG. The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci. 2012;13(4):240\u201350. https:\/\/doi.org\/10.1038\/nrn3200.","journal-title":"Nat Rev Neurosci"},{"key":"2051_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.931536","volume":"14","author":"J Lee","year":"2022","unstructured":"Lee J, Kim HJ. Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes. Front Aging Neurosci. 2022;14:931536. https:\/\/doi.org\/10.3389\/fnagi.2022.931536.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"2051_CR51","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","volume":"27","author":"MP Mattson","year":"2018","unstructured":"Mattson MP, Arumugam TV. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab. 2018;27(6):1176\u201399. https:\/\/doi.org\/10.1016\/j.cmet.2018.05.011.","journal-title":"Cell Metab"},{"issue":"7","key":"2051_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202300276","volume":"24","author":"H Huang","year":"2024","unstructured":"Huang H, van Waardenberg AJ, Graham ME, Anggono V, Widagdo J. Global quantitative proteomic analysis of aged mouse hippocampus. Proteomics. 2024;24(7):2300276. https:\/\/doi.org\/10.1002\/pmic.202300276.","journal-title":"Proteomics"},{"issue":"1","key":"2051_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0306-4522(99)00418-2","volume":"95","author":"KM Frick","year":"2000","unstructured":"Frick KM, Burlingame LA, Arters JA, Berger-Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL\/6NIA mice are affected by age and sex. Neuroscience. 2000;95(1):293\u2013307. https:\/\/doi.org\/10.1016\/s0306-4522(99)00418-2.","journal-title":"Neuroscience"},{"issue":"3","key":"2051_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11357-006-9027-3","volume":"28","author":"NC de Fiebre","year":"2006","unstructured":"de Fiebre NC, Sumien N, Forster MJ, de Fiebre CM. Spatial learning and psychomotor performance of C57BL\/6 mice: age sensitivity and reliability of individual differences. Age. 2006;28(3):235\u201353. https:\/\/doi.org\/10.1007\/s11357-006-9027-3.","journal-title":"Age"},{"issue":"6","key":"2051_CR55","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s11357-011-9320-7","volume":"34","author":"A Fahlstr\u00f6m","year":"2012","unstructured":"Fahlstr\u00f6m A, Zeberg H, Ulfhake B. Changes in behaviors of male C57BL\/6J mice across adult life span and effects of dietary restriction. Age Dordr Neth. 2012;34(6):1435\u201352. https:\/\/doi.org\/10.1007\/s11357-011-9320-7.","journal-title":"Age Dordr Neth"},{"issue":"2","key":"2051_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/npr2.12052","volume":"39","author":"H Shoji","year":"2019","unstructured":"Shoji H, Miyakawa T. Age-related behavioral changes from young to old age in male mice of a C57BL\/6J strain maintained under a genetic stability program. Neuropsychopharmacol Rep. 2019;39(2):100\u201318. https:\/\/doi.org\/10.1002\/npr2.12052.","journal-title":"Neuropsychopharmacol Rep"},{"issue":"9","key":"2051_CR57","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.neurobiolaging.2007.03.005","volume":"29","author":"I Youssef","year":"2008","unstructured":"Youssef I, Florent-B\u00e9chard S, Malaplate-Armand C, et al. N-truncated amyloid-\u03b2 oligomers induce learning impairment and neuronal apoptosis. Neurobiol Aging. 2008;29(9):1319\u201333. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.03.005.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2051_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-013-1129-2","volume":"126","author":"Y Bouter","year":"2013","unstructured":"Bouter Y, Dietrich K, Wittnam JL, et al. N-truncated amyloid \u03b2 (A\u03b2) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits. Acta Neuropathol (Berl). 2013;126(2):189\u2013205. https:\/\/doi.org\/10.1007\/s00401-013-1129-2.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"2051_CR59","doi-asserted-by":"publisher","DOI":"10.3934\/biophy.2019.1.1","volume":"6","author":"AW Pilkington","year":"2019","unstructured":"Pilkington AW, Legleiter J, Iv AWP, Legleiter J. Challenges in understanding the structure\/activity relationship of A\u03b2 oligomers. AIMS Biophys. 2019;6(1):biophy-06-01-001. https:\/\/doi.org\/10.3934\/biophy.2019.1.1.","journal-title":"AIMS Biophys"},{"key":"2051_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173273","volume":"210","author":"LJ Lissner","year":"2021","unstructured":"Lissner LJ, Wartchow KM, Toniazzo AP, Gon\u00e7alves CA, Rodrigues L. Object recognition and Morris water maze to detect cognitive impairment from mild hippocampal damage in rats: a reflection based on the literature and experience. Pharmacol Biochem Behav. 2021;210:173273. https:\/\/doi.org\/10.1016\/j.pbb.2021.173273.","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"2051_CR61","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/hipo.10154","volume":"13","author":"S Gaskin","year":"2003","unstructured":"Gaskin S, Tremblay A, Mumby DG. Retrograde and anterograde object recognition in rats with hippocampal lesions. Hippocampus. 2003;13(8):962\u20139. https:\/\/doi.org\/10.1002\/hipo.10154.","journal-title":"Hippocampus"},{"issue":"1","key":"2051_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9(1):119\u201328. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6.","journal-title":"Lancet Neurol"},{"issue":"7","key":"2051_CR63","doi-asserted-by":"publisher","first-page":"1484.e15","DOI":"10.1016\/j.neurobiolaging.2011.12.020","volume":"33","author":"D Puzzo","year":"2012","unstructured":"Puzzo D, Privitera L, Palmeri A. Hormetic effect of amyloid-\u03b2 peptide in synaptic plasticity and memory. Neurobiol Aging. 2012;33(7):1484.e15-24. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.12.020.","journal-title":"Neurobiol Aging"},{"key":"2051_CR64","doi-asserted-by":"publisher","unstructured":"Jean YY, Baleriola J, F\u00e0 M, Hengst U, Troy CM. Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus. J Vis Exp JoVE. 2015;(100). https:\/\/doi.org\/10.3791\/52805","DOI":"10.3791\/52805"},{"key":"2051_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1569181","volume":"17","author":"G Culley","year":"2025","unstructured":"Culley G, Henriques A, Hardy D, et al. Amyloid-beta peptide toxicity in the aged brain is a one-way journey into Alzheimer\u2019s disease. Front Aging Neurosci. 2025;17:1569181. https:\/\/doi.org\/10.3389\/fnagi.2025.1569181.","journal-title":"Front Aging Neurosci"},{"key":"2051_CR66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbr.2015.08.037","volume":"302","author":"SL McLean","year":"2016","unstructured":"McLean SL, Grayson B, Marsh S, Zarroug SHO, Harte MK, Neill JC. Nicotinic \u03b17 and \u03b14\u03b22 agonists enhance the formation and retrieval of recognition memory: potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders. Behav Brain Res. 2016;302:73\u201380. https:\/\/doi.org\/10.1016\/j.bbr.2015.08.037.","journal-title":"Behav Brain Res"},{"issue":"7","key":"2051_CR67","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/brain\/awac096","volume":"145","author":"E Giacobini","year":"2022","unstructured":"Giacobini E, Cuello AC, Fisher A. Reimagining cholinergic therapy for Alzheimer\u2019s disease. Brain. 2022;145(7):2250\u201375. https:\/\/doi.org\/10.1093\/brain\/awac096.","journal-title":"Brain"},{"issue":"S15","key":"2051_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/alz.076863","volume":"19","author":"F Ribaldi","year":"2023","unstructured":"Ribaldi F, Mendes AJ, Zetterberg H, et al. Plasma SNAP-25 as a potential Alzheimer\u2019s disease biomarker. Alzheimers Dement. 2023;19(S15):e076863. https:\/\/doi.org\/10.1002\/alz.076863.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2051_CR69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/JAD-215696","volume":"89","author":"Q Liu","year":"2022","unstructured":"Liu Q, Liu H, Zhang S, Yang Q, Shen L, Jiao B. Cerebrospinal fluid synaptosomal-associated protein 25 levels in patients with Alzheimer\u2019s disease: a meta-analysis. J Alzheimers Dis. 2022;89(1):121\u201332. https:\/\/doi.org\/10.3233\/JAD-215696.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2051_CR70","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0002-9440(10)63436-0","volume":"165","author":"KH Gylys","year":"2004","unstructured":"Gylys KH, Fein JA, Yang F, Wiley DJ, Miller CA, Cole GM. Synaptic changes in Alzheimer\u2019s disease: increased amyloid-\u03b2 and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am J Pathol. 2004;165(5):1809\u201317. https:\/\/doi.org\/10.1016\/S0002-9440(10)63436-0.","journal-title":"Am J Pathol"},{"issue":"14","key":"2051_CR71","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1111\/j.1742-4658.2010.07719.x","volume":"277","author":"E Pham","year":"2010","unstructured":"Pham E, Crews L, Ubhi K, et al. Progressive accumulation of amyloid-\u03b2 oligomers in Alzheimer\u2019s disease and APP transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J. 2010;277(14):3051\u201367. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07719.x.","journal-title":"FEBS J"},{"issue":"6","key":"2051_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063130","volume":"25","author":"GE Serrano","year":"2024","unstructured":"Serrano GE, Walker J, Nelson C, et al. Correlation of presynaptic and postsynaptic proteins with pathology in Alzheimer\u2019s disease. Int J Mol Sci. 2024;25(6):3130. https:\/\/doi.org\/10.3390\/ijms25063130.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2051_CR73","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/bbrc.1997.6940","volume":"236","author":"S Shimohama","year":"1997","unstructured":"Shimohama S, Kamiya S, Taniguchi T, Akagawa K, Kimura J. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer\u2019s disease. Biochem Biophys Res Commun. 1997;236(2):239\u201342. https:\/\/doi.org\/10.1006\/bbrc.1997.6940.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2051_CR74","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-510X(00)00285-9","volume":"175","author":"CI Sze","year":"2000","unstructured":"Sze CI, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer\u2019s disease brains. J Neurol Sci. 2000;175(2):81\u201390. https:\/\/doi.org\/10.1016\/S0022-510X(00)00285-9.","journal-title":"J Neurol Sci"},{"issue":"17","key":"2051_CR75","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1097\/00001756-199712010-00006","volume":"8","author":"F Dessi","year":"1997","unstructured":"Dessi F, Colle MA, Hauw JJ, Duyckaerts C. Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer\u02bcs disease. NeuroReport. 1997;8(17):3685\u20139. https:\/\/doi.org\/10.1097\/00001756-199712010-00006.","journal-title":"NeuroReport"},{"issue":"3","key":"2051_CR76","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372. https:\/\/doi.org\/10.1038\/s41582-020-00435-y.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2051_CR77","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/ijms24031869","volume":"24","author":"FL Andronie-Cioara","year":"2023","unstructured":"Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, et al. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer\u2019s Disease Progression. Int J Mol Sci. 2023;24(3):1869. https:\/\/doi.org\/10.3390\/ijms24031869.","journal-title":"Int J Mol Sci"},{"issue":"6286","key":"2051_CR78","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712\u20136. https:\/\/doi.org\/10.1126\/science.aad8373.","journal-title":"Science"},{"issue":"1","key":"2051_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ca.23792","volume":"35","author":"NS Erekat","year":"2022","unstructured":"Erekat NS. Apoptosis and its therapeutic implications in neurodegenerative diseases. Clin Anat N Y N. 2022;35(1):65\u201378. https:\/\/doi.org\/10.1002\/ca.23792.","journal-title":"Clin Anat N Y N"},{"issue":"6","key":"2051_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.118997","volume":"1868","author":"M Callens","year":"2021","unstructured":"Callens M, Kraskovskaya N, Derevtsova K, et al. The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer\u2019s disease. Biochim Biophys Acta BBA Mol Cell Res. 2021;1868(6):118997. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.118997.","journal-title":"Biochim Biophys Acta BBA Mol Cell Res"},{"issue":"5","key":"2051_CR81","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cell.2008.10.025","volume":"135","author":"P Oberdoerffer","year":"2008","unstructured":"Oberdoerffer P, Michan S, McVay M, et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell. 2008;135(5):907\u201318. https:\/\/doi.org\/10.1016\/j.cell.2008.10.025.","journal-title":"Cell"},{"issue":"7288","key":"2051_CR82","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature08983","volume":"464","author":"NA Bishop","year":"2010","unstructured":"Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature. 2010;464(7288):529\u201335. https:\/\/doi.org\/10.1038\/nature08983.","journal-title":"Nature"},{"key":"2051_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.654931","author":"A Gasiorowska","year":"2021","unstructured":"Gasiorowska A, Wydrych M, Drapich P, et al. The biology and pathobiology of glutamatergic, cholinergic, and dopaminergic signaling in the aging brain. Front Aging Neurosci. 2021. https:\/\/doi.org\/10.3389\/fnagi.2021.654931.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2051_CR84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2024.09.015","volume":"113","author":"JE Palmer","year":"2025","unstructured":"Palmer JE, Wilson N, Son SM, et al. Autophagy, aging, and age-related neurodegeneration. Neuron. 2025;113(1):29\u201348. https:\/\/doi.org\/10.1016\/j.neuron.2024.09.015.","journal-title":"Neuron"},{"issue":"1","key":"2051_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01663-1","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Tian X, Luo J, Bao T, Wang S, Wu X. Molecular mechanisms of aging and anti-aging strategies. Cell Commun Signal. 2024;22(1):285. https:\/\/doi.org\/10.1186\/s12964-024-01663-1.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2051_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7(1):391. https:\/\/doi.org\/10.1038\/s41392-022-01251-0.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02051-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02051-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02051-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:54:21Z","timestamp":1779382461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02051-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2051"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02051-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}